Stockreport

ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer

Erytech Pharma S.A. - American Depositary Shares  (ERYP) 
US:NASDAQ Investor Relations: investors.erytech.com
PDF Fast Track designation for eryaspase underscores the urgent need for potential new treatment options for patients with second line metastatic pancreatic cancer LYON [Read more]